The AMP SCZ initiative is leveraging a large investment from NIMH and public-private partners to conduct the most comprehensive, longitudinal study in individuals at risk for schizophrenia.
"ExciteOSA is a medical device designed to improve sleep for individuals with sleep apnoea, tackling issues that lead to severe health problems."